Adesão terapêutica de pacientes com cânceres de mama e próstata

Lia Raquel de Carvalho Viana; Gerlania Rodrigues Salviano Ferreira; Cláudia Jeane Lopes Pimenta; Tatiana Ferreira da Costa; Cleane Rosa Ribeiro da Silva; Kátia Neyla de Freitas Macedo Costa

doi:10.15253/2175-6783.20212262495

Authors

Lia Raquel de Carvalho Viana Universidade Federal da Paraíba https://orcid.org/0000-0002-4220-906X
Gerlania Rodrigues Salviano Ferreira Universidade Federal da Paraíba https://orcid.org/0000-0002-6956-9831
Cláudia Jeane Lopes Pimenta Universidade Federal da Paraíba https://orcid.org/0000-0002-1458-8226
Tatiana Ferreira da Costa Universidade Federal de Pernambuco https://orcid.org/0000-0002-6448-4302
Cleane Rosa Ribeiro da Silva Universidade Federal da Paraíba https://orcid.org/0000-0002-0475-2950
Kátia Neyla de Freitas Macedo Costa Universidade Federal da Paraíba https://orcid.org/0000-0003-2054-6943

DOI:

https://doi.org/10.15253/2175-6783.20212262495

Keywords:

Breast Neoplasms; Prostatic Neoplasms; Treatment Adherence and Compliance; Oncology Nursing.

Abstract

Objective: to analyze the treatment compliance of patients with breast and prostate cancers. Methods: cross-sectional study with 303 patients with breast and prostate cancers. A semi-structured instrument and the Adherence Determinants Questionnaire Scale Brazilian version were used, and the data were analyzed using descriptive and inferential statistics. Results: mean adherence was found among all participants (100.0%). In patients with prostate cancer, we observed weak correlations between age and interpersonal aspects of care (r=0.198; p=0.048); and between treatment time and intentions (r=-0.295; p=0.049). In breast cancer patients, there was a positive correlation between age and perceived support/severity (r=0.174; p=0.013); and between years of study and interpersonal aspects of care (r=0.145; p=0.038) and intentions (r=0.156; p=0.026). Conclusion: patients with breast and prostate cancers showed moderate adherence to treatment, with higher means in the Support/Severity domain and lower in the Perceived Susceptibility domain.

Deprecated: rtrim(): Passing null to parameter #1 ($string) of type string is deprecated in /var/ojs/html/plugins/generic/piwik/PiwikPlugin.inc.php on line 113

Downloads

References

Pérez YJR, Tejada BAM, Herrera JLH. Depresión en pacientes diagnosticados con cáncer en una institución de IV nivel en Montería, Colombia. Enferm Glob. 2019; 18(56):230-41. doi: https://doi.org/10.6018/eglobal.18.4.354161

International Agency of Cancer Research. Cancer today [Internet]. 2020 [cited Mar 15, 2021]. Available from: https://gco.iarc.fr/today/home

Lima MP, Machado WL, Irigaray TQ. Predictive factors of treatment adherence in cancer outpatients. Psychooncology. 2018; 27(12):2823-8. doi: https://doi.org/10.1002/pon.4897

Macêdo LM, Cavalcante VMV, Coelho MMF, Ramos SLTC, Correia DL, Menezes TAC, et al. The perception of ostomized patients with colorectal cancer regarding their quality of life. Rev Rene; 2020; 21:e43946. doi: https://doi.org/10.15253/2175-6783.20202143946

Rocha MR, Santos SD, Moura KR, Carvalho LS, Moura IH, Silva ARV. Health literacy and adherence to drug treatment of type 2 diabetes mellitus. Esc Anna Nery. 2019; 23(2):e20180325. doi: https://dx.doi.org/10.1590/2177-9465-EAN-2018-0325

Silva AG, Azevedo C, Mata LRF, Vasques CI. Adherence of patients to oral antineoplastic therapy: influential factors. Rev Baiana Enferm. 2017; 31(1):e16428. doi: https://dx.doi.org/10.18471/rbe.v31i1.16428

Bushatsky M, Silva RA, Lima MTC, Barros MBSC, Beltrão Neto JEV, Ramos YTM. Quality of life in women with breast cancer in chemotherapeutic treatment. Ciênc Cuid Saúde. 2017; 16(3):1-7. doi:https://doi.org/10.4025/cienccuidsaude.v16i3.36094

Cunha FF, Vasconcelos EV, Silva SED, Freitas KO. Oncologic patients representations about the antineoplastic chemotherapy treatment. J Res Fundam Care Online. 2017; 9(3):840-7. doi: https://doi.org/10.9789/2175-5361.2017.v9i3.840-847

Lessa PRA, Ribeiro SG, Aquino OS, Almeida PC, Pinheiro AKB. Validation of the Adherence Determinants Questionnaire scale among women with breast and cervical cancer. Rev Latino-Am Enfermagem. 2015; 23(5):971-8. doi: https://dx.doi.org/10.1590/0104-1169.0222.2638

Lee JY, Min YH. Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer. BMC Womens Health. 2018; 18:48. doi: http://doi.org/10.1186/s12905-018-0522-3

Lourenço RA, Veras RP. Mini-Mental State Examination: psychometric characteristics in elderly outpatients. Rev Saúde Pública. 2006; 40(4):712-9. doi: http://doi.org/10.1590/S0034-89102006000500023

Yee MK, Sereika SM, Bender CM, Brufsky A, Connolly MC, Rosenzweig MQ. Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer. Cancer. 2017; 123(11):2061-9. doi: https://dx.doi.org/10.1002/cncr.30575

Amador AA, Martínez ZJ, Marrugo PA, Taron DA, Diaz MA, Paut QAE. Adherencia, satisfacción al tratamiento y calidad de vida de pacientes con cáncer de mama en el Hospital Universitario del Caribe. (Cartagena, Colombia). Pharm Care Spe [Internet]. 2016 [cited Mar 11, 2021]; 18(6):251-64. Available from: https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/355/270

Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbeins JN, MacDonald JJ, et al. Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Canc Netw. 2019; 17(3):221-8. doi: https://dx.doi.org/10.6004/jnccn.2018.7098

Calvo LEA, Sepulveda-Carrillo GJ. Care needs of cancer patients undergoing ambulatory treatment. Enferm Glob. 2017; 16(45):353-83. doi: https://dx.doi.org/10.6018/eglobal.16.1.231681

Teston EF, Fukumori EFC, Benedetti GMS, Spigolon DN, Costa MAR, Marcon SS. Feelings and difficulties experienced by cancer patients along the diagnostic and therapeutic itineraries. Esc Anna Nery. 2018; 22(4):e20180017. doi: https://doi.org/10.1590/2177-9465-ean-2018-0017

Noronha IR, Pires AS, Noronha IR, Costa CMA, Ribeiro LV, Fassarella LG. Sexualidad y subjetividad: el impacto del cáncer de próstata en la vida sexual e identidad masculina. Psicooncología. 2019; 16(2):375-85. doi: https://doi.org/10.5209/psic.65597

Jacobs JM, Pensak NA, Sporn NJ, MacDonald JJ, Lennes IT, Safren SA, et al. Treatment satisfaction and adherence to oral chemotherapy in patients with cancer. J Oncol Pract. 2017; 13(5):e474-85. doi: https://doi.org/10.1200/JOP.2016.019729

Moon Z, Moss-Morris R, Hunter MS, Carlisle S, Hughes LD. Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Prefer Adherence. 2017; 11:305-22. doi: https://doi.org/10.2147/PPA.S126651

Braga DAO, Vasconcelos LL, Paiva CEQ, Prado RMS, Torres KBN. Qualidade de vida do idoso em tratamento oncológico. Rev Ciênc Méd Biol [Internet]. 2019 [cited Jan 11, 2021]; 18(2):249-53. Available from: https://www.rbspa.ufba.br/index.php/cmbio/article/view/15991/20177